It’s not a stretch to say that Christina Lake Cannabis Corp.’s (CSE:CLC) price-to-sales (or “P/S”) ratio of 0.8x right now seems quite “middle-of-the-road” for companies in the Pharmaceuticals industry in Canada, where the median P/S ratio is around 0.6x. Although, it’s not wise to simply ignore the P/S without explanation as investors may be disregarding a distinct opportunity or a costly mistake.
Check out our latest analysis for Christina Lake Cannabis
What Does Christina Lake Cannabis’ P/S Mean For Shareholders?
Christina Lake Cannabis has been doing a good job lately as it’s been growing revenue at a solid pace. It might be that many expect the respectable revenue performance to wane, which has kept the P/S from rising. Those who are bullish on…
